<b>Because there are special issues for women with uterine leiomyosarcoma, we have included some extra information.</b> 

The question of adjuvant treatment for uterine LMS after surgical excision with clear margins seems to occur often, so we have included the abstracts of medical journal articles dealing with the results of studies of this question.

Hormone replacement therapy (HRT) may be dangerous for women with uterine leiomyosarcoma, even if their tumor is read as estrogen and progestogen receptor negative. The nature of the test for the receptors involves a skilled eye, and a cut-off point, which might be 10% or 20%.... It is best to proceed exceedingly carefully here. 

But there is also the possibility of anti-hormone treatment for the uterine leiomyosarcoma.

Three of the women with Uterine LMS on the ACOR LMS list have a mother or sister who also has Uterine LMS. This has raised the question of inherited disorders. There are two medical journal articles included on this point. 

<i>The following abstracts of articles were compiled from Pubmed medical journal searches.[Parts of the abstracts have been emphasized by the compiler by placing them in bold type.
Compiler's comments will appear in brackets [such as this].]</i>
